A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy.
Doxorubicin (DOX) is widely used as a chemotherapeutic agent for both hematologic and solid tumors and is a reasonable candidate for glioma treatment. However, its effectiveness is hindered by significant toxicity and drug...
Read More